Orthopedics This Week

01/14/2026

Preventing PJI: The Window of Opportunity - Dr. Johannes F. Plate emphasizes a critical truth in our latest Master Class: the first few hours after surgery represent the greatest window of opportunity to prevent periprosthetic joint infections, before planktonic bacteria form mature biofilms that resist antibiotics and evade the immune system. He explores NanoCept, an innovative antibacterial implant coating with covalently bonded molecules that kill bacteria on contact, achieving near 100% reduction of common pathogens in vitro. From Joseph Lister's 1860s cleanliness principles to cutting-edge nanotechnology, Dr. Plate charts the evolution of infection prevention strategies.

01/13/2026

One-Stage Spacers: A Double-Edged Sword - Dr. Derek F. Amanatullah delivers a provocative analysis in our latest Master Class, arguing that one-stage revision for periprosthetic joint infections may not live up to its promise when applied beyond highly selected patients. While acknowledging the appeal of single-surgery solutions, he warns that the 60-97% eradication rate reflects cherry-picked cases and aggressive debridement—and failure means amputation or fusion, not just another spacer. His data-driven perspective challenges surgeons to weigh whether avoiding a 20% loosening rate justifies risking catastrophic outcomes in real-world practice.

01/13/2026

Registration now open for our latest Master Class!

Join us and our esteemed panel of surgeons Dr. William Hamilton, Dr. J. Bohannon Mason, and Dr. Jef Barry, on Wednesday, January 21, at 7pm EST as they discuss modern techniques and treatments for acetabular revision procedures, and their experience with CT-based surgical planning.

Wednesday, January 21, 7pm EST. Register here: https://blbmeetings.zoom.us/webinar/register/4817519983062/WN_K9y9euUlRxydVN_goVHxgA #/registration

01/10/2026

✨ MORE THAN A CONFERENCE—AN EXPERIENCE ✨

Join 100+ international faculty and colleagues from around the world at the Grand Hyatt Dubai!

🎉 Beyond the Sessions:
• Chairman's Gala Reception (January 24)
• Industry Dine-Arounds
• Exhibition Hall with daily prize drawings: iPhone 16, Apple Watch, Drones, Meta Quest!
• Networking with global orthopedic leaders
• Exploring Dubai between sessions

🏨 Accommodations:
• Grand Hyatt Dubai
• Hyatt Regency Creek Heights

🎓 Educational Value:
• 23 CME/CEU credits
• 3 specialized tracks (Arthroplasty, Sports, Trauma)
• Interactive learning format

📅 January 22-24, 2026

FREE Registration for Fellows/Residents & ME/Gulf Coast Surgeons! Code: GKS5001

Don't miss the most impactful and affordable orthopedic meeting of 2026!

Register: https://bit.ly/48ZdBQD

01/10/2026

🎓 FREE REGISTRATION ALERT! 🎓

Join your colleagues at the inaugural Global Knee Summit in Dubai, January 22-24, 2026!

They’re offering FREE registration for:
✅ Fellows & Residents (Globally)
✅ Orthopedic Surgeons from the Middle East & Gulf Coast

📍 Grand Hyatt Dubai, UAE 🏆 Up to 23 CME/CEU Credits 💉 MECOMED CVS Approved

Use Code: GKS5001

Three days of cutting-edge education in Arthroplasty, Trauma & Sports Medicine with internationally renowned faculty!
Register now: https://linkly.link/2VuOU

01/08/2026

FDA clearance secured for Ziptoe™ Hammertoe System 🔨

Key features:
✓ Pre-loaded titanium & nitinol implant
✓ Fully disposable ASC kit
✓ Eliminates K-wire complications
✓ Controlled deployment & alignment

The hammertoe segment: $350-400M annually within a foot & ankle market projected to hit $10B+ over the next decade.

Toetal Solutions is a Runway Healthcare portfolio company, formed within their venture studio model. With FDA clearance secured, the company is being positioned for strategic transaction opportunities.

Read the full story on ryortho.com

01/08/2026

Toetal Solutions has received FDA 510(k) clearance for the Ziptoe™ Hammertoe System.

Key features of Ziptoe:
→ Pre-loaded titanium and nitinol intramedullary implant
→ Fully disposable surgical kit built for ASC efficiency
→ Simple, repeatable, technique-engineered system

The hammertoe segment represents roughly $350-400M in annual global revenue. This sits within a broader foot and ankle devices market that analysts project will grow from over $5 billion today to exceed $10 billion over the next decade.

Developed by foot and ankle surgeons Drs. Stephen Soondar and Nicholas Romansky, the system was designed to address common challenges: implant handling, alignment control, and procedural simplicity.

Toetal Solutions is a Runway Healthcare portfolio company, formed within their venture studio model. With FDA clearance secured, the company is being positioned for strategic transaction opportunities.

Read the full press release on our site: https://ryortho.com/2026/01/fda-clears-toetal-solutions-ziptoe-hammertoe-system/

Toetal Solution announced that it has received FDA 510(k) clearance for its Ziptoe™ Hammertoe System.

01/08/2026

FDA Clears Toetal Solution’s Ziptoe Hammertoe System

Toetal Solution announced that it has received FDA 510(k) clearance for its Ziptoe™ Hammertoe System....

Toetal Solution announced that it has received FDA 510(k) clearance for its Ziptoe™ Hammertoe System.

01/07/2026

Two-Stage Re-Implantation: The Gold Standard? - Dr. Derek F. Amanatullah challenges conventional wisdom in our latest Master Class, questioning whether two-stage re-implantation is truly the "gold standard" for treating periprosthetic joint infections. He presents compelling evidence that durable metal and plastic spacers in a one-and-a-half stage approach can match or exceed two-stage outcomes—with fewer surgeries and less antibiotic burden for patients. His insights on reducing post-operative antibiotics and the comparable success rates of retained spacers are reshaping how we think about PJI treatment.

01/06/2026

New Tech for PJI Treatment - Dr. Nicolas S. Piuzzi tackles one of orthopedics' toughest challenges in our latest Master Class: periprosthetic joint infections (PJI), which carry mortality rates comparable to common cancers. He explores how AI and machine learning are revolutionizing patient risk assessment and care pathways, enabling surgeons to identify high-risk patients before surgery and personalize treatment approaches. Don't miss his insights on moving beyond traditional methods toward data-driven prevention strategies.